The nation of Zimbabwe has rejected a major US healthcare agreement worth 367 million US dollars (£272m) over five years because of the United States' insistence on sensitive information.
This move came to light following a official document from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".
An official representative later stated that the US was demanding access to biological samples for scientific study and profit while was not willing to guarantee the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable task of scaling back our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has appealed for further dialogue to reach a deal acceptable to all parties so the nation's critical HIV treatment initiative can continue.
Broader Background
This development comes after a comparable case in Kenya, where a high court halted a related health funding agreement following legal challenges were filed about the security of citizens' health data.
After resuming the presidency last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump claimed its expenditure was "inefficient" and his government was seeking direct bilateral deals to enhance transparency and responsibility.
As per statements, 16 African countries have so far agreed to similar health pacts, constituting over $18.3bn of fresh investment.
Details of the Declined Agreement
The money for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership could have provided immense benefits for Zimbabwean communities, particularly the 1.2 million currently on antiretroviral therapy through American-funded programmes," Tremont added.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"Our nation was requested to share its genetic material and health information over an extended period, with no corresponding promise of benefiting from any medical innovations – like new medicines or tests – that could be developed from that provided information," he stated.
"In essence, our nation would supply the basic resources for scientific discovery without any assurance that the final treatments would be available to our citizens should a future disease outbreak arise."
National Interest and International Frameworks
Mangwana further noted that the American exit from the global health body and its push of one-on-one health agreements were undermining structures already established via the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework created to manage potential pandemics.
"This framework is intended to ensure that when a country contributes its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," he added.
"We welcome continued dialogue with our American counterparts on how subsequent co-operation might be designed in a manner that honours the independence and dignity of both nations."
Health Experts Reaction
Medical experts expressed it acknowledged the official position, but suggested that talks need to persist since a large portion of the nation's HIV programmes depended on foreign aid.
"In cases where specific concerns exist, including those relating to information security or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," it commented.
The situation highlights the continuing tensions between accepting crucial foreign assistance and safeguarding a country's data in an increasingly interconnected world.